I agree with your sentiment on IDIX. Some of its current valuation is perhaps tied to a buyout similar to INHX. Would another pharma be willing to shell out billions and have the deal blow up like BMY did? Well, presumably its blown up.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.